INVESTORS & MEDIA

Corporate Governance

Date Name Title Filing Type Shares Traded Price Total Held
Dec 17, 2008
Van Plew Daniel P
SVP & GM, Ind Ops & Prod Supp
Trans History: 359
 SVP & GM, Ind Ops & Prod Supp Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 29,048 -- 29,048
Dec 11, 2019
VAGELOS P ROY
Director, Chairman of the Board
Trans History: 742
 Director, Chairman of the Board Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 29,177 -- 29,177
Aug 05, 2015
Terifay Robert J
SVP Commercial
Trans History: 172
 SVP Commercial Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 29,236 $30.63 52,529
Aug 05, 2015
Terifay Robert J
SVP Commercial
Trans History: 172
 SVP Commercial Form 4 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 29,236 -- --
Dec 14, 2010
Terifay Robert J
SVP Commercial
Trans History: 172
 SVP Commercial Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 29,236 -- 29,236
Sep 02, 2011
VAGELOS P ROY
Director, Chairman of the Board
Trans History: 742
 Director, Chairman of the Board Form 4 Open market or private sale of non-derivative or derivative security 29,529 $61.42 163,545
Apr 09, 2010
BROWN MICHAEL S
Director
Trans History: 466
 Director Form 4 Conversion of derivative security 29,662 -- 29,662
Apr 09, 2010
BROWN MICHAEL S
Director
Trans History: 466
 Director Form 4 Conversion of derivative security 29,662 -- 5,687
Jul 09, 2014
Sanofi
Ten Percent Owner
Trans History: 555
 Ten Percent Owner Form 4 Open market or private purchase of non-derivative or derivative security 29,829 $311.08 21,597,066
Jan 05, 2005
RUPP RANDALL
SVP, Manuf & Process Sciences
Trans History: 109
 SVP, Manuf & Process Sciences Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 29,902 -- 33,333

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.

Share This Page